Evidence map›Paper›PMID 33562781›Full record

ReviewMolecules (Basel, Switzerland)2021

Green Silver and Gold Nanoparticles: Biological Synthesis Approaches and Potentials for Biomedical Applications.

Andrea Rónavári, Nóra Igaz, Dóra I Adamecz, Bettina Szerencsés, Csaba Molnar, Zoltán Kónya, Ilona Pfeiffer, Monika Kiricsi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea RónaváriDepartment of Applied and Environmental Chemistry, University of Szeged, Rerrich Béla Tér 1, H-6720 Szeged, Hungary.ORCID 0000-0001-7054-0975
Nóra IgazDepartment of Biochemistry and Molecular Biology and Doctoral School of Biology, University of Szeged, Közép Fasor 52, H-6726 Szeged, Hungary.
Dóra I AdameczDepartment of Biochemistry and Molecular Biology and Doctoral School of Biology, University of Szeged, Közép Fasor 52, H-6726 Szeged, Hungary.
Bettina SzerencsésDepartment of Microbiology and Doctoral School of Biology, University of Szeged, Közép Fasor 52, H-6726 Szeged, Hungary.
Csaba MolnarBroad Institute of MIT and Harvard, Cambridge, 415 Main St, Cambridge, MA 02142, USA.
Zoltán KónyaDepartment of Applied and Environmental Chemistry, University of Szeged, Rerrich Béla Tér 1, H-6720 Szeged, Hungary.ORCID 0000-0002-9406-8596
Ilona PfeifferDepartment of Microbiology and Doctoral School of Biology, University of Szeged, Közép Fasor 52, H-6726 Szeged, Hungary.
Monika KiricsiDepartment of Biochemistry and Molecular Biology and Doctoral School of Biology, University of Szeged, Közép Fasor 52, H-6726 Szeged, Hungary.

Funding

János Bolyai Research Scholarship of the Hungarian Academy of Sciences BO/00878/19/8Nemzeti Kutatási, Fejlesztési és Innovaciós Alap GINOP-2.3.2-15-2016-00038, GINOP-2.3.2-15-2016-00035 and EFOP-3.6.1-16-2016-00008
6 · The paper itself

Abstract

The nanomaterial industry generates gigantic quantities of metal-based nanomaterials for various technological and biomedical applications; however, concomitantly, it places a massive burden on the environment by utilizing toxic chemicals for the production process and leaving hazardous waste materials behind. Moreover, the employed, often unpleasant chemicals can affect the biocompatibility of the generated particles and severely restrict their application possibilities. On these grounds, green synthetic approaches have emerged, offering eco-friendly, sustainable, nature-derived alternative production methods, thus attenuating the ecological footprint of the nanomaterial industry. In the last decade, a plethora of biological materials has been tested to probe their suitability for nanomaterial synthesis. Although most of these approaches were successful, a large body of evidence indicates that the green material or entity used for the production would substantially define the physical and chemical properties and as a consequence, the biological activities of the obtained nanomaterials. The present review provides a comprehensive collection of the most recent green methodologies, surveys the major nanoparticle characterization techniques and screens the effects triggered by the obtained nanomaterials in various living systems to give an impression on the biomedical potential of green synthesized silver and gold nanoparticles.

Indexed as

NanoparticlesBiocompatible MaterialsGoldGreen Chemistry TechnologySilverBiocompatible MaterialsGoldSilverantimicrobial activitygold nanoparticlegreen synthesisnanoparticle characterizationsilver nanoparticletoxicity

Identifiers

PMID33562781
PMCPMC7915205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.